#1 Attorneys Network
The owners of Humabs BioMed, a Swiss biotechnology firm located in Bellinzona and focused on discovering and developing fully human monoclonal antibodies to treat serious infections with a unique proprietary discovery technology, sold their interests to Vir Biotechnology.
Vir Biotechnology is founded by ARCH Venture Partners and seeded by ARCH, the Bill & Melinda Gates Foundation, Altitude Life Science Ventures, Alta Partners and further investors. Their aim is to create a global platform to transform the care of people with serious infectious diseases.
Bär & Karrer acted as legal adviser to the sellers in this transaction. The team included Paolo Bottini, Edoardo Buzzi and Paolo Ader (all M&A) and Markus Wang (IP).
The post Bär & Karrer advises on Humabs BioMed sale appeared first on The Lawyer | Legal News and Jobs | Advancing the business of law.
#1 Attorneys Search Engine